Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 2 November 2026.

Announcements

6,260

Total raised

£165B

disclosed amounts

This month

£9.0M

raised so far

Series A
£7.0M

Grafton Capital has secured a majority position in Third Financial following a £7m investment.

"Our vision for the company is to be the go-to provider of technology and custody services for investment firms. While the backbone of our operation is the servicing of traditional wealth managers and advisers, there is also a huge appetite from a raft of exciting fintech companies that require back-end operations, custody and infrastructure to help them bring their innovations to market. Our FCA-regulated service gives all of our customers a cost-effective and holistic solution which is continually updated with new features in response to client needs."
— Ian Partington, Group Chief Executive Officer
Seed
£360K

Midven led the seed financing round to support team expansion and product development.

"This investment marks a significant step forward for D-RisQ, enabling us to form a valuable partnership with Midven and the MEIF. The additional finance will accelerate the Company’s growth and provide access to additional business expertise, enabling the transition from a research and development company to a major supplier of automated software development tools."
— Nick Tudor, Chief Executive Officer
Series A
£1.5M

Parkwalk led the follow-on investment round to support the market launch of the company's mental health assessment tool.

"Diagnosing mental health issues correctly in primary care can be difficult, due to time constraints and the fact that mental health conditions can be masked by physical symptoms. Delays in diagnosing—or misdiagnosis—mean that it can take several years for an individual with depression to be correctly diagnosed. For bi-polar disorder the average delay is six to eight years. The consequence of this is that many people suffer unnecessarily from debilitating symptoms that could be successfully treated. It is clear that faster and earlier diagnosis followed by the most appropriate treatment will improve the quality of life of affected individuals, while at the same time relieving pressure on the healthcare system"
— Sabine Bahn, Laboratory Director
Series A
£3.0M

The investment was led by Calculus Capital with continued backing from Mercia Fund Management.

"We are delighted to complete a further funding round with investors who share our vision. It provides a really meaningful opportunity to capitalise on the growth opportunities emerging as the world of work continues to see accelerated change."
— Luke Fisher, CEO